Interleukin 5 activity in sera from patients with eosinophilia

Br J Haematol. 1990 Aug;75(4):458-62. doi: 10.1111/j.1365-2141.1990.tb07782.x.

Abstract

Sera from 10 patients with eosinophilia contained eosinophil colony stimulating factor (Eo-CSF) activity. Using anti murine (m) interleukin-5 (IL-5) antibody, we demonstrated that this activity was mainly derived from IL-5. Administration of prednisolone to patients decreased both Eo-CSF activity in sera and the number of eosinophils in blood. These results extend our recent study demonstrating that T cells from eosinophilic patients produce IL-5 with IL-2 stimulation and may support the speculation that IL-5 is an important factor which induces eosinophilia.

MeSH terms

  • Blood Cell Count
  • Colony-Stimulating Factors / blood
  • Eosinophilia / blood*
  • Eosinophilia / drug therapy
  • Eosinophils / metabolism
  • Humans
  • Interleukin-5 / blood*
  • Prednisolone / therapeutic use

Substances

  • Colony-Stimulating Factors
  • Interleukin-5
  • Prednisolone